NCT02311556

Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

Assessment of Early Treatment Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to evaluate whether advanced magnetic resonance imaging (MRI) techniques such as dynamic susceptibility-weighted contrast-enhanced perfusion MRI may be used to predict treatment response of brain metastasis after radiosurgery.

Conditions

• Brain Metastases

Interventions

Type	Name	Description
DEVICE	dynamic susceptibility-weighted contrast-enhanced perfusion magnetic resonance imaging

Timeline

• Start date: 2013-05-07
• Primary completion: 2016-07-01
• Completion: 2016-12-16
• First posted: 2014-12-08
• Last updated: 2017-02-24

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study